Endothelin-1-induced placental and fetal growth restriction in the rat
- PMID: 9172051
- DOI: 10.1002/(SICI)1520-6661(199705/06)6:3<125::AID-MFM1>3.0.CO;2-N
Endothelin-1-induced placental and fetal growth restriction in the rat
Abstract
The objective of this study was to evaluate the effect of increased circulating endothelin on fetal and placental growth in the rat. Indwelling arterial and venous catheters were placed on day 14 of a 22-day gestation in timed-pregnant Sprague-Dawley rats. Saline, 0.2 nmol/kg/h endothelin, or 0.5 nmol/kg/h endothelin was continuously infused from day 15 through 21 in randomly assigned animals (n = 12 in each group). Maternal arterial blood pressure and serum endothelin levels were evaluated on days 15, 18, and 21 of gestation. On day 21, pregnancy outcome data including fetal and placental weights, litter size, and the occurrence of stillbirths were ascertained, and fetal blood was obtained for serum endothelin levels. All data were compared among the three groups, and statistical significance was determined by analysis of variance. Endothelin infusion resulted in a dose-dependent decrease in fetal and placental weights when compared to saline-treated pregnancies. A significant increase in maternal arterial blood pressure was noted only in the 0.5 nmol/kg/h endothelin group. Fetal and placental growth restriction occurred in the absence of maternal hypertension in the 0.2 nmol/kg/h group. These results demonstrate that endothelin infusion causes restriction of fetal and placental growth, even in the absence of maternal hypertension.
Similar articles
-
Differential effects of endothelin A and B receptor antagonism on fetal growth in normal and nitric oxide-deficient rats.J Soc Gynecol Investig. 2001 Jan-Feb;8(1):18-23. J Soc Gynecol Investig. 2001. PMID: 11223352
-
Placental dysfunction in Suramin-treated rats: impact of maternal diabetes and effects of antioxidative treatment.J Soc Gynecol Investig. 2005 Apr;12(3):174-84. doi: 10.1016/j.jsgi.2004.12.002. J Soc Gynecol Investig. 2005. PMID: 15784502
-
Endothelin and the regulation of uteroplacental perfusion in nitric oxide synthase inhibition-induced fetal growth restriction.Placenta. 2005 Feb-Mar;26(2-3):242-50. doi: 10.1016/j.placenta.2004.06.003. Placenta. 2005. PMID: 15708126
-
Placental dysfunction in Suramin-treated rats--a new model for pre-eclampsia.Placenta. 2005 May;26(5):410-8. doi: 10.1016/j.placenta.2004.07.009. Placenta. 2005. PMID: 15850646
-
Nicotine-induced prenatal overexposure to maternal glucocorticoid and intrauterine growth retardation in rat.Exp Toxicol Pathol. 2007 Nov;59(3-4):245-51. doi: 10.1016/j.etp.2007.05.007. Epub 2007 Sep 19. Exp Toxicol Pathol. 2007. PMID: 17881205
Cited by
-
Endothelin-1 and leptin as markers of intrauterine growth restriction.Indian J Pediatr. 2009 May;76(5):485-8. doi: 10.1007/s12098-009-0079-0. Epub 2009 Apr 23. Indian J Pediatr. 2009. Retraction in: Indian J Pediatr. 2024 Aug;91(8):876. doi: 10.1007/s12098-024-05093-2 PMID: 19390804 Retracted.
-
Endothelin Receptor A Antagonism Prevents Damage to Glycogen-Rich Placental Cells Following Uterine Ischemia-Reperfusion in the Rat.Reprod Sci. 2016 Nov;23(11):1518-1525. doi: 10.1177/1933719116645190. Epub 2016 Apr 28. Reprod Sci. 2016. PMID: 27130231 Free PMC article.
-
Endothelin and platelet-activating factor: significance in the pathophysiology of ischemia/reperfusion-induced fetal growth restriction in the rat.Am J Obstet Gynecol. 2006 May;194(5):1377-83. doi: 10.1016/j.ajog.2005.11.019. Epub 2006 Mar 30. Am J Obstet Gynecol. 2006. PMID: 16579936 Free PMC article.
-
Unilateral uterine ischemia/reperfusion-induced bilateral fetal loss and fetal growth restriction in a murine model require intact complement component 5.J Reprod Immunol. 2012 Sep;95(1-2):27-35. doi: 10.1016/j.jri.2012.04.005. Epub 2012 Jun 9. J Reprod Immunol. 2012. PMID: 22688254 Free PMC article.